Source:http://linkedlifedata.com/resource/pubmed/id/14715251
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-12
|
pubmed:abstractText |
ATBF1 was first discovered as a suppressor of AFP expression in hepatocytes. It is present in brain, adult liver, lung, and gastro-intestinal tract. Recently, it has been reported that ATBF1 regulates myoblastic differentiation and interacts with v-Myb in regulation of its transactivation. Using the yeast two-hybrid system, we searched for protein-protein interactions to uncover new functions for ATBF1. We present here experimental evidence that ATBF1 is a new regulatory factor for STAT3-mediated signal transduction through its interaction with PIAS3. PIAS3 was thus identified as an ATBF1-binding protein. In co-transfection experiments, the full-length ATBF1 was found to form complexes with PIAS3 in Hep G2 cells. In the luciferase assay, ATBF1 was found to have no influence on STAT3 signaling induced by IL-6 stimulation, but it did synergistically enhance PIAS3 inhibition of activated STAT3. In conclusion, ATBF1 can suppress the IL-6-mediated cellular response by acting together with PIAS3.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Atbf1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Homeodomain Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor,
http://linkedlifedata.com/resource/pubmed/chemical/STAT3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/ZFHX3 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
314
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
97-103
|
pubmed:dateRevised |
2008-9-13
|
pubmed:meshHeading |
pubmed-meshheading:14715251-Carcinoma, Hepatocellular,
pubmed-meshheading:14715251-Carrier Proteins,
pubmed-meshheading:14715251-Cell Line, Tumor,
pubmed-meshheading:14715251-DNA-Binding Proteins,
pubmed-meshheading:14715251-Homeodomain Proteins,
pubmed-meshheading:14715251-Humans,
pubmed-meshheading:14715251-STAT3 Transcription Factor,
pubmed-meshheading:14715251-Signal Transduction,
pubmed-meshheading:14715251-Trans-Activators,
pubmed-meshheading:14715251-Two-Hybrid System Techniques
|
pubmed:year |
2004
|
pubmed:articleTitle |
ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3.
|
pubmed:affiliation |
Department of Internal Medicine and Bioregulation, Nagoya City University Graduate School of Medical Sciences 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan.
|
pubmed:publicationType |
Journal Article
|